Medtronic receives CE Mark for new carotid stent and filter

By Lisa Kerner

Erie, Pa., April 27 - Medtronic, Inc. said it received CE Mark approval for its next-generation self-expanding carotid stent and filter system, a minimally invasive treatment option to surgical procedures for the prevention of stroke.

The new Medtronic Exponent RX Self-Expanding Carotid Stent is a tiny metal scaffold that is used to prop open a blocked artery to restore adequate blood flow and prevent stroke. It is part of the Medtronic Carotid Solution, which also includes the Interceptor PLUS Carotid Filter System.

With CE Mark approval, Medtronic can market these products commercially in European countries and other international markets.

"Carotid artery disease and stroke affect hundreds of thousands of people each year, and carotid stenting offers patients a less-invasive treatment option when compared to open surgery," said Sean Salmon, vice president and general manager of Coronary and Peripheral businesses, in a news release.

Worldwide, carotid artery stenting represent a $500 million market opportunity, the release stated. Medtronic is a medical technology company located in Minneapolis.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.